Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment

Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment

A 45-year-old Italian woman, affected by relapsing−remitting multiple sclerosis (RR-MS) starting from 2011, started treatment with alemtuzumab in July 2016. Nine months after the second infusion, she had an immune thrombocytopenic purpura (ITP) with complete recovery after steroid treatmen...

Full description

Bibliographic Details
Main Authors:	Maria Chiara Buscarinu, Arianna Fornasiero, Giulia Pellicciari, Roberta Reniè, Anna Chiara Landi, Alessandro Bozzao, Cristina Cappelletti, Pia Bernasconi, Giovanni Ristori, Marco Salvetti
Format:	Article
Language:	English
Published:	MDPI AG 2019-10-01
Series:	Brain Sciences
Subjects:	multiple sclerosis autoimmune diseases immune thrombocytopenic purpura autoimmune encephalitis alemtuzumab antibodies against glur3 peptide
Online Access:	https://www.mdpi.com/2076-3425/9/11/299

Similar Items

Video Introduction for a PBL Case of Autoimmune Thrombocytopenic Purpura
by: Carol Whitfield, et al.
Published: (2012-02-01)

Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis
by: Z.F. Anabel, et al.
Published: (2024-07-01)

Expression of the AMPA receptor subunits GluR1 and GluR2 is associated with granule cell maturation in the dentate gyrus
by: Hideo eHagihara, et al.
Published: (2011-09-01)

Fulminant anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR1 antibodies encephalitis in a Chinese boy: a case report
by: Wei Han, et al.
Published: (2022-05-01)

Nerve-injury induced changes to GluR1 and GluR2/3 sub-unit expression in area 3b of adult squirrel monkeys: developmental recapitulation?
by: Todd M Mowery, et al.
Published: (2009-02-01)

DHEAS increases levels of GluR2/3 and GluR2, AMPA receptor subunits, in C57BL/6 mice hippocampus El DHEAS incrementa la expresión de GluR2/3 y GLUR2 del receptor AMPA en el hipocampo de ratones C57/BL6
by: Diego Sepúlveda Falla, et al.
Published: (2010-05-01)

Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRAN
by: Sajedeh Saeidi, et al.
Published: (2014-09-01)

Investigation of celiac disease followed by immune thrombocytopenic purpura diagnosis in patients and comparison with literature
by: Hakan Sarbay, et al.
Published: (2017-08-01)

Regulation of Fear Extinction in the Basolateral Amygdala by Dopamine D2 Receptors Accompanied by Altered GluR1, GluR1-Ser845 and NR2B Levels
by: Yan-Wei Shi, et al.
Published: (2017-06-01)

The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective survey
by: Sofia Sandgren, et al.
Published: (2023-03-01)

Pathological Mechanisms and Novel Testing Methods in Thrombotic Thrombocytopenic Purpura
by: Hallie H. Dolin, et al.
Published: (2024-03-01)

Autoimmune Thrombocytopenic Purpura in Hepatitis A Infection
by: Can Acipayam, et al.
Published: (2014-06-01)

COVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report
by: Ali Hajigholami, et al.
Published: (2023-01-01)

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
by: Paulette Esperanza Walo-Delgado, et al.
Published: (2021-10-01)

Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report
by: Farhad Mahmoudi, et al.
Published: (2023-11-01)

Neurosurgical treatment for chronic subdural hematoma in a patient with chronic autoimmune thrombocytopenic purpura
by: V V Ryzhko, et al.
Published: (2010-07-01)

Cesarean Section Combined with Splenectomy for Refractory Immune Thrombocytopenic Purpura
by: Wen-Jui Lee, et al.
Published: (2004-03-01)

Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis
by: Jianguo Yang, et al.
Published: (2024-04-01)

Case Report: Adult Still’s Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient
by: Julia Krämer, et al.
Published: (2020-08-01)

Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis
by: Goischke HK
Published: (2019-07-01)

Autoimmune Regulator Gene Polymorphisms and the Risk of Primary Immune Thrombocytopenic Purpura: A Case-Control Study
by: Muhammad T. Abdel Ghafar, et al.
Published: (2023-03-01)

Clinical Presentation and Therapy of Primary Immune Thrombocytopenia Resistant to Splenectomy
by: Aleksandar Kara-Jovanović, et al.
Published: (2020-04-01)

Presence of Idiopathic Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia in the Patients with Common Variable Immunodeficiency
by: Ramyar Asghar, et al.
Published: (2008-09-01)

Two potentially lethal conditions of probable immune origin occurring in a pregnant woman: a case report
by: H. M. Senanayake, et al.
Published: (2018-06-01)

Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control
by: Marina Rode von Essen, et al.
Published: (2023-09-01)

Low-Concentration Tributyltin Decreases GluR2 Expression via Nuclear Respiratory Factor-1 Inhibition
by: Keishi Ishida, et al.
Published: (2017-08-01)

Cerebellar degeneration and immune thrombocytopenic purpura associated with human immunodefi ciency virus infection (HIV) Degeneração cerebelar e púrpura trombocitopênica imunológica associados à infecção pelo vírus HIV
by: Clécio de Oliveira Godeiro-Júnior, et al.
Published: (2007-12-01)

Síndrome de aglutininas frías y púrpura trombocitopénica autoinmune: Un caso inusual de síndrome de Evans
by: María Elena Alfonso Valdés, et al.

Risk of secondary immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis
by: Yuying Sun, et al.
Published: (2024-04-01)

Diabetes mellitus de tipo I y púrpura trombocitopénica inmunitaria en una niña
by: José Raúl Zaldívar Ochoa, et al.

Diabetes mellitus de tipo I y púrpura trombocitopénica inmunitaria en una niña
by: José Raúl Zaldívar Ochoa, et al.

Development of a simple measurement method for GluR2 protein expression as an index of neuronal vulnerability
by: Chihiro Sugiyama, et al.
Published: (2015-01-01)

Hepatit A Enfeksiyonunda İmmün Trombositopenik Purpura
by: Can ACIPAYAM, et al.
Published: (2014-07-01)

Emerging Concepts in Immune Thrombocytopenia
by: Maurice Swinkels, et al.
Published: (2018-04-01)

Autoimmune Thrombotic Thrombocytopenic Purpura: Two Rare Cases Associated with Juvenile Idiopathic Arthritis and Multiple Sclerosis
by: Despoina Dimopoulou, et al.
Published: (2017-07-01)

Case Report: Rabies Vaccine-Induced Thrombotic Thrombocytopenic Purpura in a Patient With Systemic Lupus Erythematosus
by: Yanming Cui, et al.
Published: (2022-04-01)

Evans syndrome in children. Long-term outcome in a prospective French national observational cohort.
by: Nathalie eAladjidi, et al.
Published: (2015-09-01)

Features of a clinical course of immune cytopenias with a high titer of autoantibodies to the thyroid
by: Yu E Vinogradova, et al.
Published: (2004-07-01)

Alternative Promoters of <i>GRIK2</i> (<i>GluR6</i>) Gene in Human Carcinoma Cell Lines Are Regulated by Differential Methylation of CpG Dinucleotides
by: Vikramjit K. Zhawar, et al.
Published: (2022-03-01)

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
by: Havrdova E, et al.
Published: (2017-10-01)